Evidence map›Paper›PMID 42770476›Full record

ArticleDrug and alcohol review2026

Out of Sight, Out of Mind: Shedding Light on Two Blind Spots in Harm Reduction Discourse.

Simon Clay, Wayne Hall

Abstract read
In one paragraph

Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Simon ClayNational Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0001-6676-7608
Wayne HallNational Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Australia.ORCID https://orcid.org/0000-0003-1984-0096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Harm reduction policies aim to reduce drug-related harms. This has historically involved providing tailored health services to people who use drugs to do so more safely. Social justice is another defining element of harm reduction. This component aims to reduce drug-related stigma and minimise the social harms experienced by people who use drugs by advocating for the decriminalisation of the possession of illicit drugs. However, the harms that occur before drugs reach a user's hands or a country's borders have received less attention in harm reduction. These harms include the environmental damage that arises from illicit drug production and the humanitarian violence many individuals experience when carrying drugs across borders to escape extreme poverty and/or gang violence. In this debate piece, we highlight the extent of these harms and argue that they need to be considered when developing more comprehensive international approaches to harm reduction.

Indexed as

Harm ReductionIllicit DrugsSocial JusticeSubstance-Related DisordersHumansViolenceIllicit Drugscocainedrug legalisationenvironmental harmharm reductionhumanitarian harm

Identifiers

PMID42770476
PMCPMC13595494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.